C2718059||Personalized Medicine Approaches
C0600139||Prostate Cancer
C0450363||3D
C0029250||Organoids
C0025929||Humanized Mice
C0600139||Prostate cancer
C0600139||Prostate cancer
C4282132||malignancy
C1705493||Western
C0025266||men
C0600139||Prostate cancer
C0600139||Prostate cancer
C0178784||organ-like
C0678594||multicellular structure
C0597032||tumoral cells
C0682552||parenchymal stroma
C0225336||endothelial
C0312740||immune cells
C0243092||components
C0015350||extracellular matrix
C0015350||extracellular matrix
C0600139||Prostate cancer
C1516211||models
C0162340||understanding
C0242656||disease progression
C0521982||therapeutic responses
C1519528||Tissue slices
C1510803||monolayer cultures
C1522222||genetically engineered mouse models
C1522222||genetically engineered mouse models
C0600139||Prostate cancer
C0087111||therapy
C4050317||patient derived xenografts
C4050317||patient derived xenografts
C0600139||prostate cancer
C1819849||immune cell-tumor regulation
C0027651||tumors
C0301944||engraftments
C0600139||Prostate cancer
C1956421||tumor initiating cells
C1956421||tumor initiating cells
C0450363||three-dimensional
C0450363||3D
C0596171||tissue engineering
C2986505||genetic
C0200760||morphometric profiling
C0025929||humanized mice
C0029250||organoids
C0521982||therapeutic responses
C0025929||mice
C0020962||human immune system
C0020962||human immune system
C0039194||T-cell-
C4039583||chimeric antigen receptor-
C4039583||chimeric antigen receptor-
C0021083||immunotherapy
C0087111||therapies
C0600139||cancer
C0087111||antiproliferative
C0021083||immunotherapy
C0087111||approaches
C0600139||cancer
C2718059||precision medicine